GBECAM, NCT04540692: Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer |
|
|
| Recruiting | 3 | 444 | RoW | Docetaxel or Paclitaxel, Taxotere or Taxol, Cyclophosphamide + Doxorrubicin, Citoxan + Rubidox | Latin American Cooperative Oncology Group, Grupo Brasileiro de Estudos do Câncer de Mama (GBECAM) | Breast Cancer | 04/26 | 08/30 | | |